Wave Life Sciences, Inc. (WVE)
3.18
-0.17
(-5.07%)
USD |
NASDAQ |
Oct 23, 16:00
3.175
0.00 (0.00%)
After-Hours: 20:00
Wave Life Sciences EPS Diluted (Quarterly) : -0.34 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.34 |
| March 31, 2026 | -0.1303 |
| December 31, 2025 | -0.2952 |
| September 30, 2025 | -0.321 |
| June 30, 2025 | -0.3078 |
| March 31, 2025 | -0.2884 |
| December 31, 2024 | 0.1698 |
| September 30, 2024 | -0.466 |
| June 30, 2024 | -0.2542 |
| March 31, 2024 | -0.2441 |
| December 31, 2023 | -0.1483 |
| September 30, 2023 | 0.0654 |
| June 30, 2023 | -0.2001 |
| March 31, 2023 | -0.2685 |
| December 31, 2022 | -0.465 |
| September 30, 2022 | -0.4154 |
| June 30, 2022 | -0.6212 |
| March 31, 2022 | -0.6248 |
| December 31, 2021 | -0.6102 |
| September 30, 2021 | -0.1229 |
| June 30, 2021 | -0.7757 |
| March 31, 2021 | -0.8648 |
| December 31, 2020 | -0.5902 |
| September 30, 2020 | -0.8628 |
| June 30, 2020 | -1.151 |
| Date | Value |
|---|---|
| March 31, 2020 | -1.378 |
| December 31, 2019 | -1.653 |
| September 30, 2019 | -1.480 |
| June 30, 2019 | -1.224 |
| March 31, 2019 | -1.356 |
| December 31, 2018 | -1.286 |
| September 30, 2018 | -1.283 |
| June 30, 2018 | -1.232 |
| March 31, 2018 | -1.262 |
| December 31, 2017 | -1.106 |
| September 30, 2017 | -0.9184 |
| June 30, 2017 | -0.9144 |
| March 31, 2017 | -0.8965 |
| December 31, 2016 | -0.79 |
| September 30, 2016 | -0.75 |
| June 30, 2016 | -0.51 |
| March 31, 2016 | -0.36 |
| December 31, 2015 | -0.47 |
| September 30, 2015 | -0.54 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -0.1781 |
| CorMedix, Inc. | 0.281 |
| Eloxx Pharmaceuticals, Inc. | -0.6631 |
| Breakthrough Chemistry, Inc. | -0.1113 |
| BioStem Technologies, Inc. | -0.5178 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -69.36M |
| Revenue (Quarterly) | 2.272M |
| Total Expenses (Quarterly) | 71.63M |
| Enterprise Value | 167.61M |
| Gross Profit Margin (Quarterly) | -4.27% |
| Profit Margin (Quarterly) | -3.05K% |
| Earnings Yield | -34.17% |
| Normalized Earnings Yield | -34.17 |